Adaptive Biotechnologies (ADPT) Short-Term Debt to Capital
Adaptive Biotechnologies (ADPT) automates immunity analysis through robotic systems and AI, eliminating manual labor. A digital gene database ensures the seamless scaling of new diagnostic tests. As confirmed by the price history on the chart, the debt-to-equity ratio currently stands at 0.23. However, future profit growth will be limited by a dependence on the willingness of US insurers to reimburse these medical studies.
Metric breakdowns and analytics for adaptivebiotech.com (ADPT)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Total Debt to Capital Adaptive Biotechnologies|ADPT - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Adaptive Biotechnologies Corporation|ADPT - Aggregate Debt Obligations|Debts to Book Capitalization Adaptive Biotech|ADPT - Long-Term Debt Volume|Company Short-Term Debt Adaptive Biotechnologies
Comprehensive company analysis:Adaptive Biotechnologies Corp, ADPT
To objectively assess the issuer's solvency, it is critical to analyze the long-term debt-to-equity ratio, which determines the company's degree of dependence on borrowed funds. The trend of the short-term debt-to-equity ratio reveals liquidity risks, which for Adaptive Biotechnologies (ADPT) during its period of restructuring and pursuit of Big Pharma alliances represents a balance between financial stability and the resources necessary for organic survival.
Competing companies
Argenx (ARGX) - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital BioNTech Pharma (BNTX)|Short-Term Debt to Capital ABVX (Abivax Pharma)|admabiologics.com - Short-Term Debt to Capital|Short-Term Debt to Equity Protagonist (PTGX)|IMVT: Ratio of Short-Term Indebtedness to Capital|KNSA (Kiniksa Pharmaceuticals Ltd) - Short-Term Debt to Equity|Grifols Biemat (GRFS) - Short-Term Debt to Equity Ratio|CLDX (Celldex Therapeutics) - Short-Term Debt to Capital|Short-Term Debt to Capital auriniapharma.com (AUPH)|BioCryst Pharmaceuticals (BCRX) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Vera Therapeutics Inc (VERA)|Short-Term Debt to Capital DNTH|Pharvaris Pharma - Short-Term Debt to Capital Coefficient|ABCL: Short-Term Debt to Equity|TRML: Short-Term Debt to Equity Ratio|PGEN (Precigen) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Pharming Group NV|NKTR (Nektar) - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital UPB|Short-Term Debt to Equity Zenas Biopharma Inc ZBIO|Short-Term Debt to Capital Ratio immunome.com (IMNM)|GOSS: Short-Term Debt to Capital|Current Liabilities to Capital KalVista Pharma KALV|Septerna Corp - Short-Term Debt to Capital|PVLA - Short-Term Debt to Capital|Short-Term Debt to Capital Savara Inc.|rigel.com (RIGL) - Short-Term Debt to Capital Ratio|ANAB (AnaptysBio) - Short-Term Debt to Capital|Short-Term Debt to Capital ATXS|ENGN - Short-Term Debt to Equity|Current Liabilities to Equity rapt.com RAPT|Short-Term Debt to Equity Ratio Aerovate Therapeutics (JBIO)|Short-Term Loans to Capital Ratio aclaristx.com ACRS|Short-Term Debt to Capital KYTX (Kyverna Therapeutics, Inc.)|Tiziana Life Sciences Ltd. (TLSA) - Short-Term Debt to Capital Coefficient|Cabaletta Bio, Inc (CABA) - Short-Term Debt to Equity Ratio|Ventyx Biosciences, Inc (VTYX) - Short-Term Debt to Equity|Short-Term Debt to Capital THTX (Theratechnologies Inc.)|Current Liabilities to Capital avalotx.com (AVTX)|Eledon Pharmaceuticals, Inc. (ELDN) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Agenus, Inc. (AGEN)|Short-Term Debt to Capital Climb Bio, Inc. CLYM|Short-Term Debt to Equity zurabio.com ZURA|Short-Term Debt to Capital ATYR (aTyr Pharma, Inc.)|ADAG: Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity IMA|Current Liabilities to Capital Shattuck Labs|Equillium Inc (EQ) - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Connect Pharma|Immunic, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital atarabio.com (ATRA)|InflaRx - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio X4 Pharmaceuticals Inc. XFOR|Short-Term Debt to Capital Adicet (ACET)|CELU: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity INmune Bio, Inc.|BRNS (barinthusbio.com) - Short-Term Debt to Capital Ratio|Short-Term Debt to Equity KZR (Kezar Life Sciences, Inc.)|Current Liabilities to Capital SABS|Short-Term Debt to Equity Akari Therapeutics plc (AKTX)|Short-Term Debt to Equity ENLV (enlivex.com)|QTTB: Short-Term Debt to Equity|Current Liabilities to Capital geovax.com GOVX|Short-Term Debt to Capital EDSA|IBIO - Short-Term Indebtedness to Equity|carismatx.com - Short-Term Debt to Capital|XTL Bio (XTLB) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital BOLT (Bolt Biotherapeutics Inc.)|Current Liabilities to Capital HCWB|APVO (Aptevo Therapeutics) - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient aimimmuno.com (AIM)|Short-Term Debt to Capital ADTX (Aditxt, Inc.)|Short-Term Debt to Capital GRI Bio Corporation GRI|XORTX Therapeutics Inc. (XRTX) - Short-Term Debt to Capital|HIND: Short-Term Debt to Capital Ratio|Short-Term Debt to Equity Revelation Biosciences, Inc. (REVB)|Current Liabilities to Equity Indaptus Therapeutics Inc|Scinai (SCNI) - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio CALI|AFMD - Short-Term Debt to Equity|Current Liabilities to Equity allakos.com (ALLK)|Short-Term Debt to Capital HOOKIPA Pharma|Ratio of Short-Term Indebtedness to Capital IGM Biosciences Inc. IGMS|iTeos - Short-Term Debt to Capital|OCEA: Short-Term Debt to Capital|Short-Term Debt to Equity TC Biopharm TCBP|THRD (thirdharmonicbio.com) - Ratio of Short-Term Indebtedness to Capital